Carregant...
Miniatura

Tipus de document

Article

Versió

Versió publicada

Data de publicació

Llicència de publicació

cc-by-nc-nd (c) McClain, Shannan P. et al.; Elsevier, 2023
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/207999

In vivo photopharmacology with light-activated opioid drugs

Títol de la revista

Director/Tutor

ISSN de la revista

Títol del volum

Resum

Traditional methods for site-specific drug delivery in the brain are slow, invasive, and difficult to interface with recordings of neural activity. Here, we demonstrate the feasibility and experimental advantages of in vivo photopharmacology using "caged" opioid drugs that are activated in the brain with light after systemic administration in an inactive form. To enable bidirectional manipulations of endogenous opioid receptors in vivo, we developed photoactivatable oxymorphone (PhOX) and photoactivatable naloxone (PhNX), photoactivatable variants of the mu opioid receptor agonist oxymorphone and the antagonist naloxone. Photoactivation of PhOX in multiple brain areas produced local changes in receptor occupancy, brain metabolic activity, neuronal calcium activity, neurochemical signaling, and multiple pain- and reward-related behaviors. Combining PhOX photoactivation with optical recording of extracellular dopamine revealed adaptations in the opioid sensitivity of mesolimbic dopamine circuitry in response to chronic morphine administration. This work establishes a general experimental framework for using in vivo photopharmacology to study the neural basis of drug action.

Matèries (anglès)

Citació

Citació

MCCLAIN, Shannan p., MA, Xiang, JOHNSON, Desiree a., JOHNSON, Caroline a., LAYDEN, Aryanna e., YUNG, Jean c., LUBEJKO, Susan t., LIVRIZZI, Giulia, HE, X jenny, ZHOU, Jingjing, CHANG-WEINBERG, Janie, VENTRIGLIA, Emilya, RIZZO, Arianna, LEVINSTEIN, Marjorie, GOMEZ, Juan l., BONAVENTURA, Jordi, MICHAELIDES, Michael, BANGHART, Matthew r.. In vivo photopharmacology with light-activated opioid drugs. _Neuron_. 2023. Vol. 111, núm. 24, pàgs. 3926-3940. [consulta: 25 de febrer de 2026]. ISSN: 0896-6273. [Disponible a: https://hdl.handle.net/2445/207999]

Exportar metadades

JSON - METS

Compartir registre